Drug – bio-affecting and body treating compositions – Extract – body fluid – or cellular material of undetermined... – Tissue – other than lymphoid tissue
Patent
1994-11-16
1998-02-03
Low, Christopher S. F.
Drug, bio-affecting and body treating compositions
Extract, body fluid, or cellular material of undetermined...
Tissue, other than lymphoid tissue
424572, 424422, 424423, 424424, 424425, 424 932, 424 9321, 6048901, 435 911, 4352851, 536 231, A61K 3512
Patent
active
057141703
ABSTRACT:
A method of inducing resistance to tumor growth comprising placing tumor cells in culture supplemented with an agent in a diffusion chamber thereby producing a cell-containing chamber, inserting the chamber into a mammal for a therapeutically effective time, thereby inducing resistance to tumor growth.
REFERENCES:
patent: 5077059 (1991-12-01), Mishima et al.
patent: 5262308 (1993-11-01), Baserga
patent: 5272082 (1993-12-01), Santoli et al.
Becker et al. 1992, EMBO J. 8(12): 3685-3691.
Brown, D. 1995, "Gene Therapy `Oversold` By Researchers, Journalists" in: The Washington Post, 8 Dec. 1995, pp. 1 and A22.
Kolata, G., 1995, "In the rush toward gene therapy, some see a high risk of failure", in: The New York Times, 25 Jul. 1995, p. C3.
Marshall, E., 1995, Science 269: 1050-1055.
Miller et al. 1994, Parasitology Today, 10(3): 92-97.
Wu-Pong, S. 1994, Pharmaceutical Technology, Oct. 1994, pp. 102, 104, 106, 108, 110-112, and 114.
Tseng et al. 1994, Cancer Gene Therapy, 1(1): 65-71.
Conley, F. K. 1974, J. Neurosurg. 41: 332-338.
Ray et al. Ca.sup.2+ antagonists inhibit DNA fragmentation and toxic cell death induced by acetaminophen The FASEB Journal 1993 7:453-463.
Sell et al., Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor Proc. Natl. Acad. Sci. USA 1993, 90:11217-11221.
Sell et al., Effect of a Null Mutationof the Insulin-Like Growth Factor I Receptor Gene on Growth and Transformation of Mouse Embryo Fibroblasts Mol. Cell. Biol. 1994, 14:3604-3612.
Valentinis et al., The role of the insulin-like growth factor I receptor in the transformation by simian virus 40 T antigen Oncogene 1994, 9:825-831.
Coppola et al., A Functional Insulin0Like Growth Factor I Receptor is Required for the Mitogenic and Transforming Activities of the Epidermal Growth Factor Receptor Mol. Cell. Biol. 1994, 14:4588-4594.
Resnicoff et al., Rat Glioblastoma Cells Expressing an Antisense RNA to the Insulin-like Growth Factor-1 (IGF-1) Receptor are Nontumorigenic and Induce Regression o Wild-Type Tumors Cancer Res. 1994, 54:2218-2222.
Resnicoff, M., et al., Growth Inhibition of Human Melanoma Cells in Nude Mice by Antisense Strategies to the Type 1 Insulin-like Growth Factor Receptor Cancer Res. 1994, 54:4848-4850.
Harrington et al., c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines EMBO J. 1994, 13:3286-3295.
Goldring and Goldring, Cytokines and Cell Growth Control Crit. Rev. Eukaryot. Gene Expr. 1991, 1:301-326.
Baserga and Rubin, Cell Cycle and Growth Control Crit. Rev. Eukaryot. Gene Expr. 1993, 3:47-61.
Pietrzkowski et al., Constitutive Expression of Insulin-like Growth Factor 1 and Insulin-like Growth Factor 1 Receptro Abrogates All Requirements for Exogenous Growth Factors Cell Growth & Diff 1992, 3:199-205.
Pietrzkowski et al., Roles of Insulinlike Growth Factor 1 (IGF-1) and the IGF-1 Receptor in Epidermal Growth Factor-Stimulated Growth of 3T3 Cells Mol. Cell. Biol. 1992, 12:3883-3889.
Buttyan, R., et al., Induction of the TRPM-2 Gene in Cells Undergoing Programmed Death Mol Cell Biol 1989, 9:3473-3481.
Kaufmann, S.H., Induction of Endonucleolytic DNA Cleavage in Human Acute Myelogenous Leukemia Cells by Etoposide, Camptothecin, and Other Cytotoxic Anticancer Drugs: A Cautionary Note Cancer Res 1989, 49:5870-5878.
Barry, M.A., et al., Activiation of Programmed Cell Death by Cisplatin, Other Anticancer Drugs, Toxins and Byperthermia Biochem Pharmacol, 1990, 40:2353-2362.
Bursch, W., et al., Determination of the length of the histological states of apoptosis in normal liver and in altered hepatic foci of rats Carcinogenesis 1990, 11:847-853.
Lange et al., IL-4-and IL-5-Dependent Protective Immunity to Onchocerca Volvulus infective Larvae in BALB/cBYJ mice J. Immunol. 1994, 153:205-211.
Lanza et al., Xenogeneic Humoral Responses to Islets Transplated in Biohybrid Diffusion Chambers Transplantation, 1994, 57:1371-1375.
Trojan et al., Treatment and Prevention of Rat Glioblastoma by Immunogenic C6 Cells Expressing Antisense Insulin-Like Growth Factor I RNA Science 1993, 259:94-97.
Martin et al., Development of a in Vitro Assay for the Survival of Cells Suspended from BA1112 Rat Sarcomas Eur. J. Cancer Clin. Oncol. 1983, 19:791-797.
Preston et al Regulation of Apoptosis by Low Serum in Cells of Different Stages of Neoplastic Progression Cancer Res. 1994 54:4214-4223.
Abraham David
Baserga Renato
Resnicoff Mariana
Low Christopher S. F.
Thomas Jefferson University
LandOfFree
Method of inducing resistance to tumor growth does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inducing resistance to tumor growth, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inducing resistance to tumor growth will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-660151